- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06451081
Brief Behavioural Economic Intervention for Smoking Cessation (QTW2024)
Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2024: a Randomised Controlled Trial of a Brief Behavioural Economic Intervention
Study Overview
Status
Conditions
Detailed Description
Smoking cessation services are free and effective but underused in Hong Kong. Active referral to smoking cessation services has consistently been found effective in promoting service use and successful quitting as a stand-alone strategy or when combined with other interventions. Participants who received active referral are introduced about the cessation services in Hong Kong and offered connection to the services of their choices. Contacts of participants who agreed to be referred are transferred to the selected cessation providers, who will subsequently contact the participants for further treatment.
The current active referral intervention uses an opt-in approach, where participants are required to actively choose to be connected to the services. By leveraging behavioural economic principles, a simple yet promising strategy to strengthen the active referral intervention is to utilize an "opt-out" approach, where participants are automatically referred to the service unless they actively decline the referral. By making referral to smoking cessation services as the default choice, the investigators aim to increase the uptake of these services and thus improve smoking cessation outcomes. Additionally, mobile messaging informed by behavioural economics principles can serve as nudges to prompt smokers to initiate quitting and utilise cessation services.
The clinical trial aims to test the effectiveness of opt-out referral, with or without behavioural economic-based mobile messaging, compared to opt-in referral, in promoting smoking cessation. The trial will be nested within the 15th "Quit to Win" Smoke-free Community Campaign organised by the Hong Kong Council on Smoking and Health.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tzu Tsun Luk, PhD, RN
- Phone Number: 39177574
- Email: luktt@connect.hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Community Sites
-
Contact:
- Tzu Tsun Luk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hong Kong residents aged 18 years or above
- Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
- Exhaled carbon monoxide level ≥4 parts per million or a positive salivary cotinine test
- Able to communicate in and read Chinese
- Own a smartphone with a mobile instant messaging app installed
Exclusion Criteria:
- Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Opt-out+ group
Brief cessation advice + Opt-out active referral + behavioural economics mobile messaging
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Participants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out.
Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality
Participants will receive behavioural economics-informed messages via mobile instant messaging for 3 months
|
|
Experimental: Opt-out group
Brief cessation advice + Opt-out active referral
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Participants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out.
Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality
|
|
Active Comparator: Opt-in group
Brief cessation advice + Opt-in active referral
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Participants will be offered a referral to a smoking cessation service.
Contacts of participants who opt-in will be delivered to a service provider of their choice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemically validated tobacco abstinence
Time Frame: 6 months after randomisation
|
Verified by an exhaled carbon monoxide level of <4 parts per million and a negative salivary cotinine test
|
6 months after randomisation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemically validated tobacco abstinence
Time Frame: 3 months after randomisation
|
Verified by an exhaled carbon monoxide level of <4 parts per million and a negative salivary cotinine test
|
3 months after randomisation
|
|
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 3 months after randomisation
|
Tobacco abstinence in the past 7 days
|
3 months after randomisation
|
|
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 6 months after randomisation
|
Tobacco abstinence in the past 7 days
|
6 months after randomisation
|
|
Self-reported 24-hour quit attempt
Time Frame: 3 months after randomisation
|
Tobacco abstinence for at least 24 hours
|
3 months after randomisation
|
|
Self-reported 24-hour quit attempt
Time Frame: 6 months after randomisation
|
Tobacco abstinence for at least 24 hours
|
6 months after randomisation
|
|
Self-reported use of smoking cessation service
Time Frame: 3 months after randomisation
|
Use of any smoking cessation service during the follow-up period
|
3 months after randomisation
|
|
Self-reported use of smoking cessation service
Time Frame: 6 months after randomisation
|
Use of any smoking cessation service during the follow-up period
|
6 months after randomisation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported reduction of tobacco consumption
Time Frame: 3 months after randomisation
|
Smoking reduction by at least half of the baseline daily number of cigarettes
|
3 months after randomisation
|
|
Self-reported reduction of tobacco consumption
Time Frame: 6 months after randomisation
|
Smoking reduction by at least half of the baseline daily number of cigarettes
|
6 months after randomisation
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tzu Tsun Luk, PhD, RN, The University of Hong Kong
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- QTW2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Smoking
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
University of Colorado, DenverUniversity of OklahomaRecruitingSmoking Cessation | Tobacco | Quitting Smoking | Tobacco Abstinence | Smoking (Tobacco) Addiction | Smoking ( Cigarette)United States
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)CompletedTobacco Smoking | Cigarette Smoking | Smoking, TobaccoUnited States
-
University of ArizonaNational Center for Complementary and Integrative Health (NCCIH); West Virginia...CompletedSmoking Cessation | Tobacco Use | Tobacco Smoking | Smoking, Tobacco | Guided ImageryUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
RAI Services CompanyNot yet recruitingSmoking | TobaccoUnited States
-
RAI Services CompanyTerminatedSmoking | TobaccoUnited States
-
RAI Services CompanyCompletedSmoking | Tobacco Use | Tobacco Smoking | Smoking BehaviorsUnited States
Clinical Trials on Brief cessation advice
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Washington University School of MedicineNational Institute on Drug Abuse (NIDA)CompletedSmoking Cessation | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
Clinica Universidad de Navarra, Universidad de...Government of NavarraCompletedSmoking Cessation | Health Behavior | Health Personnel AttitudeSpain
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
The University of Hong KongChinese University of Hong KongCompletedSmoking | Smoking Cessation | Emergency Service, Hospital | Evidence-Based NursingHong Kong
-
The University of Hong KongHong Kong Council on Smoking and HealthCompletedSmoking CessationHong Kong
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted
-
The University of Hong KongNot yet recruiting
-
Beijing Normal UniversityNot yet recruitingSmoking Cessation | Mobile HealthChina
-
The University of Hong KongCompletedSmoking CessationHong Kong